Preclinical Models of Uveal Melanoma: Strengths, Limitations, and Translational Utility
Pigment Cell & Melanoma Research · 2026-11 · 39 (6)
DOI: 10.1111/pcmr.70142 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 09.11.2026. Verfasst von Yunxi Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma, Translational Research, Biomedical. Die Arbeit nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and is characterized by a high propensity for metastatic dissemination, particularly to the liver, which remains largely incurable. Despite advances in the molecular characterization of UM, progress in therapeutic development has been limited, in part due to the lack of preclinical models that faithfully recapitulate the biological complexity and clinical behavior of the disease. A wide range of in vitro and in vivo systems have been developed, including primary cultures and established cell lines, three‐dimensional (3D) cultures, patient‐derived organoids (PDOs), xenografts, and genetically engineered animal models. Each of these models captures specific aspects of UM biology but also presents inherent limitations related to genetic drift, microenvironmental context, immune interactions, and metastatic fidelity. In this review, we provide an overview of current preclinical models used to study UM, with a focus on the strengths and limitations of each system. We also discuss emerging strategies to improve model fidelity and translational relevance. Continued development of integrated and physiologically relevant models will be essential to bridge the gap between discovery and clinical application in UM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
- Department of Pathology, McGill University, Montreal, Quebec, Canada.
- Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Yunxi Chen, Mohamed Abdouh, Julia V Burnier
Förderung
- Fonds de Recherche du Québec - Santé
Zitieren
APA
Chen, Y., Abdouh, M., & Burnier, J. V. (2026). Preclinical Models of Uveal Melanoma: Strengths, Limitations, and Translational Utility. Pigment Cell & Melanoma Research, 39(6). https://doi.org/10.1111/pcmr.70142
Vancouver
Chen Y, Abdouh M, Burnier JV. Preclinical Models of Uveal Melanoma: Strengths, Limitations, and Translational Utility. Pigment Cell & Melanoma Research. 2026;39(6). doi:10.1111/pcmr.70142
BibTeX
@article{Chen2026,
author = {Chen, Yunxi and Abdouh, Mohamed and Burnier, Julia V},
title = {Preclinical Models of Uveal Melanoma: Strengths, Limitations, and Translational Utility},
journal = {Pigment Cell & Melanoma Research},
year = {2026},
volume = {39},
number = {6},
doi = {10.1111/pcmr.70142}
}
EUVIMED